Compare Stocks: ETG, IE, NSU, and SLS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund	$23.08 -1.0%	$23.69	$19.34 ▼ $24.71	N/A	N/A	118,730 shs	68,490 shs
IE Ivanhoe Electric	$10.64 +0.8%	$10.24	$7.86 ▼ $21.55	$1.69B	1.26	2.19 million shs	2.88 million shs
NSU Nevsun Resources	$4.44 -0.2%	$4.44	$2.23 ▼ $4.58	$1.38B	N/A	87,058 shs	25,500 shs
SLS SELLAS Life Sciences Group	$11.59 -0.2%	$12.40	$1.39 ▼ $15.88	$2.34B	2.52	6.30 million shs	3.75 million shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund	-0.97%	-1.36%	-5.33%	-2.02%	+10.91%
IE Ivanhoe Electric	+0.76%	+8.02%	-4.92%	+10.72%	-11.26%
NSU Nevsun Resources	0.00%	0.00%	0.00%	0.00%	0.00%
SLS SELLAS Life Sciences Group	-0.17%	+1.93%	-12.26%	-21.48%	+611.04%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund	$23.08 -1.0%	$23.69	$19.34 ▼ $24.71	N/A	N/A	118,730 shs	68,490 shs
IE Ivanhoe Electric	$10.64 +0.8%	$10.24	$7.86 ▼ $21.55	$1.69B	1.26	2.19 million shs	2.88 million shs
NSU Nevsun Resources	$4.44 -0.2%	$4.44	$2.23 ▼ $4.58	$1.38B	N/A	87,058 shs	25,500 shs
SLS SELLAS Life Sciences Group	$11.59 -0.2%	$12.40	$1.39 ▼ $15.88	$2.34B	2.52	6.30 million shs	3.75 million shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund	-0.97%	-1.36%	-5.33%	-2.02%	+10.91%
IE Ivanhoe Electric	+0.76%	+8.02%	-4.92%	+10.72%	-11.26%
NSU Nevsun Resources	0.00%	0.00%	0.00%	0.00%	0.00%
SLS SELLAS Life Sciences Group	-0.17%	+1.93%	-12.26%	-21.48%	+611.04%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund	0.00	N/A	N/A	N/A
IE Ivanhoe Electric	3.00	Buy	$17.33	62.91% Upside
NSU Nevsun Resources	0.00	N/A	N/A	N/A
SLS SELLAS Life Sciences Group	2.33	Hold	$10.00	-13.72% Downside

Current Analyst Ratings Breakdown

Latest ETG, IE, NSU, and SLS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/25/2026	IE Ivanhoe Electric	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Sector Outperform	$18.00 ➝ $16.00
8/12/2026	SLS SELLAS Life Sciences Group	Alliance Global Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
7/17/2026	SLS SELLAS Life Sciences Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/9/2026	IE Ivanhoe Electric	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$21.00 ➝ $20.00
7/6/2026	SLS SELLAS Life Sciences Group	Alliance Global Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy

(Data available from 9/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund	$492.14M	N/A	N/A	N/A	N/A	N/A
IE Ivanhoe Electric	$3.24M	524.09	N/A	N/A	$2.93 per share	3.63
NSU Nevsun Resources	N/A	N/A	N/A	N/A	N/A	N/A
SLS SELLAS Life Sciences Group	N/A	N/A	N/A	N/A	$0.46 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IE Ivanhoe Electric	-$105.87M	-$1.59	N/A	N/A	N/A	-3,899.97%	-26.29%	-23.02%	11/4/2026 (Estimated)
NSU Nevsun Resources	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SLS SELLAS Life Sciences Group	-$26.86M	-$0.21	N/A	N/A	N/A	N/A	-35.91%	-33.34%	11/11/2026 (Estimated)

Latest ETG, IE, NSU, and SLS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/11/2026	Q2 2026	SLS SELLAS Life Sciences Group	-$0.0450	-$0.05	-$0.0050	-$0.05	N/A	N/A
8/7/2026	Q2 2026	IE Ivanhoe Electric	-$0.1167	$0.16	+$0.2767	$0.16	$1.00 million	$0.72 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund	$1.55	6.71%	N/A	N/A	N/A
IE Ivanhoe Electric	N/A	N/A	N/A	N/A	N/A
NSU Nevsun Resources	N/A	N/A	N/A	N/A	N/A
SLS SELLAS Life Sciences Group	N/A	N/A	N/A	N/A	N/A

Latest ETG, IE, NSU, and SLS Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
9/1/2026	ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund	monthly	$0.1293	6.75%	9/15/2026	9/15/2026	9/30/2026
8/3/2026	ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund	monthly	$0.1293	6.35%	8/14/2026	8/14/2026	8/31/2026
7/1/2026	ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund	monthly	$0.1293	6.65%	7/15/2026	7/15/2026	7/31/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund	N/A	N/A	N/A
IE Ivanhoe Electric	N/A	5.05	5.05
NSU Nevsun Resources	N/A	N/A	N/A
SLS SELLAS Life Sciences Group	N/A	18.83	18.83

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund	N/A
IE Ivanhoe Electric	79.05%
NSU Nevsun Resources	N/A
SLS SELLAS Life Sciences Group	17.38%

Insider Ownership

Company	Insider Ownership
ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund	N/A
IE Ivanhoe Electric	11.30%
NSU Nevsun Resources	N/A
SLS SELLAS Life Sciences Group	1.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund	N/A	N/A	N/A	Not Optionable
IE Ivanhoe Electric	286	159.59 million	141.56 million	Not Optionable
NSU Nevsun Resources	N/A	309.75 million	N/A	Not Optionable
SLS SELLAS Life Sciences Group	13	201.95 million	199.32 million	Not Optionable

ETG, IE, NSU, and SLS Headlines

Recent News About These Companies

SELLAS Life Sciences präsentiert auf der AACR-Konferenz 2026 zu Bauchspeicheldrüsenkrebs präklinische Daten zur Wirksamkeit von SLS009 in Pankreaskrebsmodellen

September 26 at 1:39 AM | de.marketscreener.comD

SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer

September 25, 2026 | globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS

September 24, 2026 | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS

September 22, 2026 | globenewswire.com

SELLAS Life Sciences: Valued For Perfection, REGAL Trial Success Probability Priced In

September 21, 2026 | seekingalpha.com

SELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap Down - Should You Sell?

September 17, 2026 | marketbeat.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS

September 17, 2026 | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS

September 15, 2026 | globenewswire.com

SELLAS Life Sciences Group (NASDAQ:SLS) Shares Down 4.8% - Here's Why

September 11, 2026 | marketbeat.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS

September 10, 2026 | prnewswire.com

Wellington Management Group LLP Grows Stock Holdings in SELLAS Life Sciences Group, Inc. $SLS

September 9, 2026 | marketbeat.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS

September 8, 2026 | globenewswire.com

SELLAS Life Sciences Group, Inc. (SLS)

September 4, 2026 | finance.yahoo.com

Bank of New York Mellon Corp Makes New Investment in SELLAS Life Sciences Group, Inc. $SLS

September 4, 2026 | marketbeat.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS

September 3, 2026 | prnewswire.com

SELLAS Life Sciences Group (SLS) Lands 3 AACR Abstracts For SLS009 Pancreatic Cancer Data

September 3, 2026 | finance.yahoo.com

Most and least shorted mid- to mega-cap healthcare stocks at the end of August

September 2, 2026 | seekingalpha.com

Sellas gears up to present preclinical SLS009 data for pancreatic cancer at major oncology conference

September 2, 2026 | msn.com

SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer

September 2, 2026 | globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SELLAS Life Sciences Group, Inc. - SLS

September 1, 2026 | globenewswire.com

Why analysts think Sellas Life Sciences stock can gain 150% from here

September 1, 2026 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ETG, IE, NSU, and SLS Company Descriptions

Eaton Vance Tax-Advantaged Global Dividend Income Fund NYSE:ETG

$23.08 -0.23 (-0.98%)

Closing price 09/28/2026 03:58 PM Eastern

Extended Trading

$23.06 -0.02 (-0.07%)

As of 09/28/2026 07:30 PM Eastern

Eaton Vance Tax-Advantaged Global Dividend Income Fund is a closed ended equity mutual fund launched and managed by Eaton Vance Management. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in dividend paying value stocks of companies. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the MSCI World Index. Eaton Vance Tax-Advantaged Global Dividend Income Fund was formed on November 14, 2003 and is domiciled in the United States.

Ivanhoe Electric NYSEAMERICAN:IE

$10.64 +0.08 (+0.76%)

Closing price 09/28/2026 04:10 PM Eastern

Extended Trading

$10.80 +0.16 (+1.54%)

As of 09/28/2026 07:56 PM Eastern

Ivanhoe Electric Inc. explores and develops metals and mineral. The company provides Typhoon data acquisition system, a geophysical system that offers primary signal. It also explores copper and gold. The company was incorporated in 2020 and is headquartered in Tempe, Arizona.

Nevsun Resources NYSEAMERICAN:NSU

$4.44 -0.01 (-0.22%)

As of 03/7/2019

Nevsun Resources Ltd. engages in the mining and development of mineral properties in Europe, Africa, and North America. It explores for gold, copper, zinc, and silver deposits. The company's principal assets include Timok project, a copper-gold development project in Serbia; and Bisha copper- zinc mine in Eritrea. It also holds exploration licenses and permits in Serbia and Macedonia, as well as in the Bisha mining district. The company was incorporated in 1965 and is headquartered in Vancouver, Canada. As of January 7, 2019, Nevsun Resources Ltd. operates as a subsidiary of Zijin Mining Group Company Limited.

SELLAS Life Sciences Group NASDAQ:SLS

$11.59 -0.02 (-0.17%)

Closing price 09/28/2026 04:00 PM Eastern

Extended Trading

$11.52 -0.07 (-0.63%)

As of 09/28/2026 07:57 PM Eastern

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ETG, IE, NSU, and SLS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ETG, IE, NSU, and SLS Earnings

Compare Dividends

Latest ETG, IE, NSU, and SLS Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ETG, IE, NSU, and SLS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ETG, IE, NSU, and SLS Company Descriptions

Eaton Vance Tax-Advantaged Global Dividend Income Fund NYSE:ETG

Ivanhoe Electric NYSEAMERICAN:IE

Nevsun Resources NYSEAMERICAN:NSU

SELLAS Life Sciences Group NASDAQ:SLS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools